RWJ 67657

• Description :

  A potent, selective, orally active p38 MAPK inhibitor that inhibits the production of TNF-α and IL-1β by LPS-stimulated human PBMCs with IC50 of 3 and 11 nM, respectively.

• CAS Number :

  215303-72-3

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  425.5

• Molecular Formula :

  C27H24FN3O

• Notes :

  Research use only, not for human use.

• Receptor :

  P38 MAPK